BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 36465240)

  • 1. Retracted: Reversal of Radiotherapy Resistance of Ovarian Cancer Cell Strain CAOV3/R by Targeting lncRNA CRNDE.
    Healthcare Engineering JO
    J Healthc Eng; 2022; 2022():9763145. PubMed ID: 36465240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of Radiotherapy Resistance of Ovarian Cancer Cell Strain CAOV3/R by Targeting lncRNA CRNDE.
    Yang W; Li X; Zhao L; Zhao F
    J Healthc Eng; 2021; 2021():8556965. PubMed ID: 34540189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. lncRNA CRNDE is Upregulated in Glioblastoma Multiforme and Facilitates Cancer Progression Through Targeting miR-337-3p and ELMOD2 Axis [Retraction].
    Onco Targets Ther; 2020; 13():12721. PubMed ID: 33328742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA CRNDE regulates the growth and migration of prostate cancer cells by targeting microRNA-146a-5p.
    Fu D; Zang L; Li Z; Fan C; Jiang H; Men T
    Bioengineered; 2021 Dec; 12(1):2469-2479. PubMed ID: 34232111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA CRNDE promotes cell proliferation, migration and invasion of ovarian cancer via miR-423-5p/FSCN1 axis.
    Wang Q; Wang LX; Zhang CY; Bai N; Feng C; Zhang ZM; Wang L; Gao ZZ
    Mol Cell Biochem; 2022 May; 477(5):1477-1488. PubMed ID: 35166986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA CRNDE inhibits cardiomyocytes apoptosis by YAP1 in myocardial ischaemia/reperfusion injury.
    Zhu X; Li S; Huang C; Huang G; Xu J
    Autoimmunity; 2021 Jun; 54(4):204-212. PubMed ID: 33988471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retracted: CRNDE/ETS1/GPR17 Facilitates the Proliferation, Migration, and Invasion of Glioma.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9814841. PubMed ID: 37811263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA CRNDE is involved in radiation resistance in hepatocellular carcinoma via modulating the SP1/PDK1 axis.
    Chen KY; Zhu SG; He JW; Duan XP
    Neoplasma; 2022 Jul; 69(4):918-930. PubMed ID: 35652619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Impact of cyclin-dependent kinase inhibitor p27 on resistance of ovarian cancer multicellular spheroids to taxol].
    Xing H; Li J; Gao QL; Wu JH; Gao C; Lu YP; Ma D
    Zhonghua Yi Xue Za Zhi; 2003 Jan; 83(1):37-41. PubMed ID: 12757643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRNDE inducing cisplatin resistance through SRSF1/TIA1 signaling pathway in ovarian cancer.
    Wu J; Ni X; Yu Z; Wu S; Liu Z
    Pathol Res Pract; 2022 Jul; 235():153957. PubMed ID: 35653925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long non-coding RNA CRNDE competed endogenously with miR-205 to promote proliferation and metastasis of melanoma cells by targeting CCL18.
    Xu L; Zhang Y; Zhao Z; Chen Z; Wang Z; Xu S; Zhang X; Liu T; Yu S
    Cell Cycle; 2018; 17(18):2296-2308. PubMed ID: 30257602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retracted: Immune Subtype Profiling and Establishment of Prognostic Immune-Related lncRNA Pairs in Human Ovarian Cancer.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9758427. PubMed ID: 37475952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The long non-coding RNA
    Ding X; Zhang Y; Liang J; Yin J; Akbar N; Miguel V; Zhou Y
    Ann Transl Med; 2022 Aug; 10(15):835. PubMed ID: 36034978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. lncRNA CRNDE promotes the proliferation and metastasis by acting as sponge miR-539-5p to regulate POU2F1 expression in HCC.
    Li Z; Wu G; Li J; Wang Y; Ju X; Jiang W
    BMC Cancer; 2020 Apr; 20(1):282. PubMed ID: 32252678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retracted: lncRNA GAS5 Induces Cell Apoptosis in Acute Myeloid Leukemia by Targeting Nrf2.
    Markers D
    Dis Markers; 2023; 2023():9808761. PubMed ID: 37502590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of the long noncoding RNA CRNDE-h indicates a poor prognosis in colorectal cancer, and is positively correlated with IRX5 mRNA expression.
    Liu T; Zhang X; Yang YM; Du LT; Wang CX
    Onco Targets Ther; 2016; 9():1437-48. PubMed ID: 27042112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA CRNDE and lncRNA SNHG7 are Promising Biomarkers for Prognosis in Synchronous Colorectal Liver Metastasis Following Hepatectomy.
    Zhang P; Shi L; Song L; Long Y; Yuan K; Ding W; Deng L
    Cancer Manag Res; 2020; 12():1681-1692. PubMed ID: 32210611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA CRNDE promotes hepatocellular carcinoma progression by upregulating SIX1 through modulating miR-337-3p.
    Tang D; Zhao L; Peng C; Ran K; Mu R; Ao Y
    J Cell Biochem; 2019 Sep; 120(9):16128-16142. PubMed ID: 31099050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long Noncoding RNA CRNDE/PRC2 Participated in the Radiotherapy Resistance of Human Lung Adenocarcinoma Through Targeting p21 Expression.
    Zhang M; Gao C; Yang Y; Li G; Dong J; Ai Y; Chen N; Li W
    Oncol Res; 2018 Sep; 26(8):1245-1255. PubMed ID: 28550688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA CRNDE functions as a diagnostic and prognostic biomarker in osteosarcoma, as well as promotes its progression via inhibition of miR-335-3p.
    Yu Y; Wang L; Li Z; Zheng Y; Shi Z; Wang G
    J Biochem Mol Toxicol; 2021 May; 35(5):e22734. PubMed ID: 33522065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.